Resolving Mixed-Culture Results Through Re-isolation and Repeat Testing

Welcome. This module addresses the situations in which an automated ID–AST result cannot safely be treated as the result of a single organism. Mixed cultures are a high-consequence source of error: an analyzer may generate a technically complete identification, MIC panel, and susceptibility categories even when the inoculum contains more than one bacterial population.

In this lesson, you will learn a defensible workflow for resolving that situation: recognize the warning signs on culture plates, separate the organisms, establish purity, repeat identification and AST from each pure isolate, and ensure that only verified results reach the clinical record.

---

1. Why a mixed culture invalidates a “single-isolate” automated result

Automated bacterial identification and susceptibility systems assume that the suspension loaded into the card or panel represents one pure organism at a standardized density. If two organisms, or two distinct strains, enter the same suspension, the instrument measures their combined or competing growth. It cannot reliably assign each biochemical reaction, growth curve, or MIC endpoint to one member of the mixture.

The resulting error is not necessarily obvious. A mixed inoculum may produce:

• an inconclusive or low-confidence ID;
• an ID–AST combination that conflicts with expected biology;
• unusual growth patterns or skipped wells;
• an apparently plausible, fully released result that actually reflects only the faster-growing or more abundant organism.

The last scenario is the most dangerous. A more susceptible organism can dominate the growth signal, masking a resistant organism and producing an AST profile that is falsely susceptible. Conversely, a resistant contaminant can make a clinically relevant pathogen appear more resistant than it is.

A mixed culture can arise at several points:

Situation	What it means	Immediate implication
True polymicrobial specimen	More than one organism was present in the patient sample, such as a complicated wound, intra-abdominal specimen, or occasionally blood culture.	Each clinically significant isolate needs independent workup.
Contamination during collection	A non-pathogenic or skin-associated organism entered the specimen during collection.	Do not dismiss it solely from morphology; evaluate specimen type, culture pattern, and clinical context.
Laboratory contamination	An organism entered during handling, subculture, or inoculum preparation.	Investigate workflow and maintain traceability.
Mixed strains of one species	Two colony variants may share an ID but differ in resistance phenotype.	Keep variants separate until identification and AST establish whether they are meaningfully different.

A key principle follows:

Do not interpret or “average” MICs from a mixed inoculum. MICs and susceptibility categories belong to a defined organism isolate tested under defined conditions.

---

2. Plate review is the decisive first check

When an automated result is unexpected, the first question is usually not “What resistance mechanism explains this?” It is:

Was the inoculum pure?

Review the primary culture and, where relevant, the purity plate or subculture made from the inoculum. For a positive blood culture, compare the Gram stain morphology with the colonies recovered on subculture. For non-blood specimens, examine whether the colony types fit the specimen source and the original culture description.

During plate review, look systematically for:

1. More than one colony morphology
   Differences in size, color, edge, elevation, texture, hemolysis, swarming, odor, pigment, or lactose/chromogenic reaction can indicate mixed organisms.

2. An inconsistent Gram stain
   For example, both cocci and rods, mixed Gram reactions, or clearly different cellular morphologies are strong evidence against purity.

3. A discordance between colony morphology and automated output
   A plate showing two colony types but one definitive analyzer result is not reassurance. It means the analyzer may have selected the dominant population.

4. Different morphotypes of the apparent same organism
   Two E. coli-like colonies, for example, may still represent separate strains. If they differ in morphology, source, or preliminary phenotype, retain them separately rather than pooling them.

5. A suspicious culture distribution
   A single atypical colony in a heavy pure culture may be contamination; equal growth of two morphotypes may be true polymicrobial infection. Both require initial separation before a final conclusion.

Colony morphology is a screening tool, not final identification. Conversely, a uniform-looking plate is not absolute proof of purity: some species and strain variants look very similar. When clinical consequences are substantial, a Gram stain or another purity check from the selected colony can provide important confirmation.

---

3. A practical purity-and-retest workflow

The following workflow applies whether the alert came from plate review, a Gram-stain mismatch, a surprising automated result, or an analyzer warning.

Finding at review	Action	Status of original automated result
One uniform colony type, consistent Gram stain, plausible ID–AST	Continue standard verification procedures.	May be acceptable if all other checks pass.
Two or more distinct colony morphologies	Pick each morphotype separately and re-isolate.	Hold; do not report as a single isolate.
Mixed Gram morphologies	Re-isolate organisms from appropriate colonies; compare with specimen Gram stain.	Hold.
Culture appears contaminated	Re-streak the suspected target organism; consider selective media according to SOP.	Hold or amend if a preliminary report has been issued.
Inconclusive ID, no growth, growth in all wells, or skipped wells	Check purity and inoculum preparation, then repeat from a pure isolate.	Invalid for final reporting.
Repeat AST yields a substantial categorical change	Consider mixed culture, inoculum error, or a true unusual phenotype. Maintain separate isolates and investigate.	Do not select whichever result appears more plausible.

The NARMS Interagency Laboratory Manual provides a useful model of this discipline: purity is established on blood agar or MacConkey agar before automated testing, and cultures that appear mixed undergo further isolation or selective-media workup. Although your clinical laboratory must follow its own validated SOPs and current manufacturer instructions, the underlying logic is universal: purity precedes identification and AST.

---

4. Re-isolation: turn one uncertain culture into traceable pure isolates

Re-isolation is not simply “pick another colony.” Its purpose is to create a documented, pure descendant culture for each distinct population observed.

Separate before you identify

For each distinct morphotype:

1. Assign a separate temporary isolate designation.
   Preserve the link to the original specimen and plate, but do not assume that colonies are the same organism because they arose from the same specimen.

2. Pick a well-isolated colony, not confluent growth.
   Avoid sweeping several colonies together. A sweep can recreate the original mixed inoculum.

3. Streak for isolation onto an appropriate nonselective medium.
   Blood agar is commonly useful for observing colonial purity and hemolysis. Use selective or differential media only when indicated by organism type, specimen context, or laboratory policy.

4. Incubate under organism-appropriate validated conditions.
   Incubation atmosphere, temperature, and duration must be suitable for recovery. Do not force a routine overnight workflow onto a slow-growing or fastidious organism.

5. Review the derived plate before testing.
   A pure isolate should yield a uniform colony population consistent with the colony originally selected. If it does not, repeat isolation again.

For difficult mixtures, selective media can help enrich or recover the target organism. The method must be chosen with a purpose. For example, selective Campylobacter media may be appropriate for a suspected mixed Campylobacter culture, whereas Enterococcosel agar may help recover Enterococcus from a mixed specimen. Selective media are aids to separation, not substitutes for confirming purity of the final test colony.

Two practices are especially important:

• Do not discard a second morphotype before characterizing it. It may be the resistant organism that the original automated AST masked.
• Do not pool “similar-looking” colonies. If two variants are potentially clinically significant, maintain separate workups until evidence shows they can appropriately be treated as one isolate under laboratory policy.

---

5. Repeat ID and AST from the pure culture

Once each isolate is demonstrably pure, repeat testing begins from the clean culture—not from the original mixed suspension and not by modifying the prior MIC interpretation.

Repeat identification

Run identification separately for each pure isolate. The exact platform may be MALDI-TOF, VITEK 2, MicroScan, BD Phoenix, conventional biochemistry, or a reference method. At this stage, check whether:

• each colony type produces a distinct species-level identification;
• the ID is consistent with colony morphology and Gram stain;
• the original automated ID matched one of the recovered organisms;
• two different morphotypes are actually the same species but potentially different strains.

If identification remains unreliable, do not force species-level reporting from a low-confidence result. Follow the laboratory’s escalation path, which may include repeat preparation, an alternative identification method, or referral.

Repeat AST

Perform AST for each pure, clinically relevant isolate using a standardized inoculum and the validated organism–drug–method combination.

The prior test should be regarded as invalid for final susceptibility reporting because its inoculum composition was unknown. Repeat the applicable full panel rather than selecting only drugs that were “interesting” or discordant. This avoids an unrecognized mismatch between drug results generated from different inocula.

Compare the repeat profile with the original cautiously:

• If one pure isolate matches the original result and another is more resistant, the original mixed test likely reflected the susceptible or faster-growing population.
• If the repeat result is substantially different but purity is now confirmed, investigate technical causes and possible unusual phenotypes rather than assuming the first result was simply wrong.
• If repeated pure isolates produce the same ID but different AST categories, preserve both results and determine whether both strains should be reported according to specimen type and laboratory policy.

A direct-inoculation VITEK 2 study illustrates the risk. In polymicrobial blood culture samples, some mixed cultures still produced conclusive identifications. In several cases, the susceptibility profile reflected the more susceptible bacillus, which could have led to a falsely reassuring report. This does not establish a current reporting policy for direct testing; it demonstrates why purity review remains essential even when an instrument result looks internally coherent.

---

6. Holding, correcting, and reporting results

A mixed culture affects not only the bench result but also the integrity of the LIS record and clinical communication.

Before final release

When mixed culture is suspected:

• place the original automated ID and AST result on hold;
• document why the result is being investigated;
• record each colony morphotype and its separate temporary identifier;
• retain traceability from specimen to primary plate, purity plate, repeat ID, repeat AST, and final report;
• confirm that the corrected results, comments, and suppressed tests transfer accurately into the LIS.

If a preliminary result has already been communicated, follow the local policy for amended reporting and urgent notification. A preliminary identification that has been invalidated by mixed growth should not remain in the chart without clear correction.

Final reporting logic

The final report should represent the verified clinical finding, not merely the analyzer output.

• One pathogenic isolate plus likely contaminant: report and AST the pathogen; handle the contaminant according to specimen-specific policy and clinical relevance.
• Two clinically significant organisms: report each organism separately, each with its own susceptibility result where testing is indicated.
• Mixed growth that cannot yet be resolved: report only a qualified preliminary statement permitted by policy, such as mixed growth under investigation, and avoid organism-specific susceptibility claims.
• No recoverable pure isolate: document the limitation and consider repeat specimen collection where clinically appropriate.

For bloodstream infections, a suspected mixed culture is particularly urgent because antimicrobial selection and infection-control decisions may depend on it. The laboratory should communicate verified critical information promptly, while being equally careful not to communicate unverified species-level or susceptibility results as final.

---

7. Bench-side resolution checklist

Use this as a compact sequence when an automated result may come from a mixed culture:

1. Stop release of the automated result.
2. Review the primary plate, purity plate, and Gram stain for evidence of more than one organism.
3. Document each morphotype and assign separate isolate identifiers.
4. Pick and streak each morphotype independently until a pure derived culture is obtained.
5. Confirm purity by uniform colony morphology and appropriate microscopic or other checks.
6. Repeat ID independently for every relevant pure isolate.
7. Repeat AST independently from standardized inocula for every relevant isolate.
8. Reconcile results with the original analyzer output, expected organism biology, QC status, and specimen context.
9. Report only verified organism-specific results and amend any invalid preliminary information.
10. Document the investigation for traceability, quality review, and possible process improvement.

---

Mixed cultures are a reminder that automation does not replace culture interpretation. An analyzer can generate a polished-looking answer from an invalid input; plate review and purity control determine whether that answer belongs to a real, reportable isolate.

The central takeaways are that mixed cultures must be recognized before result release, distinct morphotypes must be re-isolated rather than pooled, and both ID and AST must be repeated from verified pure cultures. The next lesson will build on this workflow by distinguishing a likely technical error from a plausible unusual resistance phenotype once culture purity has been established.